The return on equity (ROE) for the stock stood at 9.7 per cent. Traded volume on the counter stood at 12:04PM shares and turnover at Rs 3.5 crore around that time. The stock of Biocon Ltd. quoted a 52-week high price of Rs 487.7 and 52-week low prices of Rs 320.9, respectively.
The stock’s Beta value, which measures its volatility in relation to the broader market, stood at 0.98.
Promotor/FII Holding
Promoters held 39.75 per cent stake in the company as of 31-Mar-2021, while FIIs held 16.3 per cent and domestic institutional investors had 2.51 per cent.
Key Financials
The company reported consolidated sales of Rs 2044.1 crore for the quarter ended 31-Mar-2021, up 8.79 per cent from previous quarter’s Rs 1878.9 crore and up 24.33 per cent from the year-ago quarter’s Rs 1644.1 crore. Net profit after tax for the latest quarter stood at Rs 253.2 crore, up 105.19 per cent from the same quarter a year ago.
Technicals
The MACD signalled a bearish bias on the counter. The MACD is known for signalling trend reversals in traded securities or indices.
It is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average, called the signal line, is plotted on topof the MACD to reflect “buy” or “sell” opportunities. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may see a downward movement and vice versa.
